B.Braun Wound Management and Infection Control
Oil of hyperoxygenated fatty acids
Skin Care
Skin Care
Skin Care
Skin Care
Skin Care
Skin Care
Skin Care
Application on face
Application on non-blanchable Erythema
Linovera® is a solution of hyperoxygenated fatty acids used in the prevention and treatment of Stage I pressure ulcers. Due to the high percentage of linoleic acid, its repairing action is increased. The vegetable extracts – aloe vera and centella asiatica – have a major protecting and healing effect on the skin.
Advantages
Lubricates the skin.
Reduces shear and friction.(1)
Maintains the moisture barrier function of the skin.(2)(3)
Contains more than 75% of linoleic acid which is crucial for maintaining the structure of the epidermal barrier.(4)
Contains Aloe vera which acts as an emollient and humectant as well as Centella asiatica, a skin tonic, soothing agent.(5)
Composition: Hyperoxygenated essential fatty acids (linoleic acid), Aloe Vera, Centella Asiatica, Perfume
Available in 10 ml and 30 ml
Indication
Prevention and treatment of Stage I pressure ulcers
References:
1) Jiménez Torres, J. Ãcidos Grasos Hiperoxigenados (AGHO) en el tratamiento y prevención de las úlceras por presión, úlceras vasculares y pie diabético. Panorama actual del medicamento 2010; 34 (336): 695-701.
2) Declair V. The usefulness of topical application of essential fatty acids (EFA) to prevent pressure ulcers. Ostomy Wound Manage. 1997;43(5):48-52, 54.
3) Colin D; Chomard D; Bois C; Saumet JL, Desvaux B; Marie M. An evaluation of hyper-oxygenated fatty acid esters in pressure sore management. J Wound Care. 1998;7(2):71-2.
4) Kiezel-Tsugunova M; Kendall AC, Nicolaou A. Fatty acids and related lipid mediators in the regulation of cutaneous inflammation. Biochem Soc Trans. 2018 Feb 19;46(1):119-129. doi: 10.1042/BST20160469 Ajouter au projet Citavi par DOI. Epub 2018 Jan 12. PMID: 29330355 Ajouter au projet Citavi par Pubmed-ID.
5) Cravotto G. et all. An evaluation of the potential of 1000 plants. Journal of Clinical Pharmacy and Therapeutics, 2010 35:1:11-48
Oil of hyperoxygenated fatty acids
Skin Care
Skin Care
Skin Care
Skin Care
Skin Care
Skin Care
Skin Care
Application on face
Application on non-blanchable Erythema
Linovera® is a solution of hyperoxygenated fatty acids used in the prevention and treatment of Stage I pressure ulcers. Due to the high percentage of linoleic acid, its repairing action is increased. The vegetable extracts – aloe vera and centella asiatica – have a major protecting and healing effect on the skin.
Advantages
Lubricates the skin.
Reduces shear and friction.(1)
Maintains the moisture barrier function of the skin.(2)(3)
Contains more than 75% of linoleic acid which is crucial for maintaining the structure of the epidermal barrier.(4)
Contains Aloe vera which acts as an emollient and humectant as well as Centella asiatica, a skin tonic, soothing agent.(5)
Composition: Hyperoxygenated essential fatty acids (linoleic acid), Aloe Vera, Centella Asiatica, Perfume
Available in 10 ml and 30 ml
Indication
Prevention and treatment of Stage I pressure ulcers
References:
1) Jiménez Torres, J. Ãcidos Grasos Hiperoxigenados (AGHO) en el tratamiento y prevención de las úlceras por presión, úlceras vasculares y pie diabético. Panorama actual del medicamento 2010; 34 (336): 695-701.
2) Declair V. The usefulness of topical application of essential fatty acids (EFA) to prevent pressure ulcers. Ostomy Wound Manage. 1997;43(5):48-52, 54.
3) Colin D; Chomard D; Bois C; Saumet JL, Desvaux B; Marie M. An evaluation of hyper-oxygenated fatty acid esters in pressure sore management. J Wound Care. 1998;7(2):71-2.
4) Kiezel-Tsugunova M; Kendall AC, Nicolaou A. Fatty acids and related lipid mediators in the regulation of cutaneous inflammation. Biochem Soc Trans. 2018 Feb 19;46(1):119-129. doi: 10.1042/BST20160469 Ajouter au projet Citavi par DOI. Epub 2018 Jan 12. PMID: 29330355 Ajouter au projet Citavi par Pubmed-ID.
5) Cravotto G. et all. An evaluation of the potential of 1000 plants. Journal of Clinical Pharmacy and Therapeutics, 2010 35:1:11-48